本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

4D Molecular Therapeutics

2.99
-0.2400-7.43%
盘后2.990.00000.00%16:20 EDT
成交量:154.62万
成交额:461.26万
市值:1.38亿
市盈率:-1.00
高:3.23
开:3.21
低:2.87
收:3.23
数据加载中...

公司资料

公司名字:
4D Molecular Therapeutics
交易所:
NASDAQ
成立时间:
2013
员工人数:
227
公司地址:
5858 Horton Street,Suite 455,Emeryville,California,United States
邮编:
94608
电话:
传真:
- -
简介:
4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家领先的临床阶段生物制药公司,专注于通过针对特定疾病治疗进行优化的专有定制载体释放基因药物的全部潜力。

董事

名称
职位
David Kirn
Chief Executive Officer and Director
John F. Milligan
Executive Chairman
David Schaffer
Director and Chief Scientific Advisor
Charles Theuer
Director
Jacob Chacko
Director
Nancy Miller Rich
Director
Shawn Cline Tomasello
Director
Susannah Gray
Director
Tony Yao
Director
William Burkoth
Director

股东

名称
职位
David Kirn
Chief Executive Officer and Director
Fred Kamal
Chief Operating Officer and Chief Technical Officer
August Moretti
Chief Financial Officer
David Schaffer
Director and Chief Scientific Advisor
Peter Francis
Chief Scientific Officer
Robert Fishman
Chief Medical Officer
Theresa Janke
Chief Strategy Officer